IDO checkpoint inhibitors (Harbin Gloria Pharmaceuticals/Ensemble Therapeutics)

N/A

Report date: 2025/06/11 10:37:35
NME

Base Information

Drug NameIDO checkpoint inhibitors (Harbin Gloria Pharmaceuticals/Ensemble Therapeutics)
Drug Alias NameIDO checkpoint inhibitors (Ensemble Therapeutics)E-040280E-039132
ClassificationSmall molecules
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsImmunostimulantsT lymphocytes stimulants
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEnsemble Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Gloria Pharmaceuticals Co Ltd
Inactive CompaniesEnsemble Therapeutics Corp
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A